We developed MSC-laden microcarriers in spinner flask culture as cell delivery vehicles to solve those difficulties in alleviating the progression of osteoarthritis by using exogenous MSC.

We genetically engineered MSCs with Exendin-4 (MSC-Ex-4), a glucagon-like peptide-1 (GLP-1) analog, and demonstrated their boosted cellular functions and antidiabetic efficacy in the type 2 diabetes mellitus (T2DM) mouse model.

We developed the 3D‐MAPS as a platform technology to rapidly fabricate centimeter‐sized functional tissue constructs with complex structures

We demonstrate the different patterns of AYM changes in epithelial and mesenchymal cell types on substrates with different stiffness

We rationally developed targeted delivery strategy leveraging transglutaminase (TGase) expressed on the surface of MSCs and inflammatory (ECs)

We develop customized 3D biomaterials and collabrate with Jianhao Lin, M.D. in Peking University People's Hospital for pathological study and regenerative therapy

Congratulation to the graduates

Our paper about 3D TableTrix (the porous microcarrier tablet) has been made the front cover on Tissue Engineering